Dexcom g7 continuous glucose monitor is for patients two years and older with any type of diabetes including type 1, type 2, or gestational diabetes. The dexcom g7 continuous glucose monitoring system (dexcom g7 cgm system or g7) is a glucose monitoring system indicated for continuously measuring glucose in the interstitial fluid in persons age 2 years and older, including pregnant women. Dexcom g7 is a continuous glucose monitoring (cgm) system
Dexcom g7 comes with a sensor you wear on the skin that's held in place with an overpatch.
The g7 can be used for treatment decisions and does not require fingerstick calibration.
The dexcom g7 continuous glucose monitoring (cgm) system is now cleared in the us for all people with diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution. The g7 is approved for people with all types of diabetes ages 2 years and older In february of this year, dexcom released clinical trial data demonstrating strong blood sugar measurement accuracy. Yes, dexcom g7 continuous glucose monitoring (cgm) system is indicated for pediatric patients two years and older with any type of diabetes.